Qiang Zhang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Machine Learning

Positive Breast Cancer

Inflammatory Response

Estrogen Receptor

Top Venues

EMBO molecular medicine

Cancer biology & medicine

Journal of breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine (2023)
Yusong Wang, Mozhi Wang, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lyu, Mingke Cui, Qiang Zhang, Yingying Xu
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity. Cancer biology & medicine 20 (3) (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine (2023)
Ruina Luan, Mingcong He, Hao Li, Yu Bai, Anqi Wang, Ge Sun, Baosheng Zhou, Manlin Wang, Chunyu Wang, Shengli Wang, Kai Zeng, Jianwei Feng, Lin Lin, Yuntao Wei, Shigeaki Kato, Qiang Zhang, Yue Zhao
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer. EMBO molecular medicine 16 (1) (2023)
Yusong Wang, Mozhi Wang, Keda Yu, Shouping Xu, Pengfei Qiu, Zhidong Lyu, Mingke Cui, Qiang Zhang, Yingying Xu
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity. Cancer biology & medicine 20 (3) (2023)
Litong Yao, Zhiyuan Pang, Mozhi Wang, Mengshen Wang, Xiangyu Sun, Mingke Cui, Yanfu Zheng, Xinyan Li, Haoran Dong, Qiang Zhang, Yingying Xu
The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study. Cancer biology & medicine (2021)
Xinyan Li, Mozhi Wang, Mengshen Wang, Xueting Yu, Jingyi Guo, Tie Sun, Litong Yao, Qiang Zhang, Yingying Xu
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy. Journal of breast cancer 22 (4) (2019)